Seven lots of norgestimate and ethinyl estradiol tablets distributed to U.S. pharmacies between Sept. 21 and Dec. 30, 2011, "could leave women without adequate contraception, and at risk for unintended pregnancy."
"Select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only on the outer pouch," the company said in a statement released Friday, explaining the packaging error.
The correct packaging aligns 28 tablets in four rows, with the white tablets containing norgestimate and ethinyl estradiol in the top row and light green placebo tablets in the bottom row.
Read more...
No comments:
Post a Comment